Willingdon Wealth Management Decreased Epr Pptys (EPR) Stake; BREATHTEC BIOMEDICAL ORD (BTHCF) SI Increased By 104.86%

January 14, 2018 - By Ellis Scott

BREATHTEC BIOMEDICAL ORD (OTCMKTS:BTHCF) had an increase of 104.86% in short interest. BTHCF’s SI was 160,200 shares in January as released by FINRA. Its up 104.86% from 78,200 shares previously. With 459,000 avg volume, 0 days are for BREATHTEC BIOMEDICAL ORD (OTCMKTS:BTHCF)’s short sellers to cover BTHCF’s short positions. The stock decreased 12.46% or $0.04 during the last trading session, reaching $0.26. About 1.69 million shares traded or 411.48% up from the average. Breathtec Biomedical, Inc. (OTCMKTS:BTHCF) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Willingdon Wealth Management decreased Epr Pptys (EPR) stake by 24.6% reported in 2017Q3 SEC filing. Willingdon Wealth Management sold 14,132 shares as Epr Pptys (EPR)’s stock declined 5.17%. The Willingdon Wealth Management holds 43,310 shares with $3.02M value, down from 57,442 last quarter. Epr Pptys now has $4.39B valuation. The stock decreased 1.13% or $0.68 during the last trading session, reaching $59.62. About 409,684 shares traded. EPR Properties (NYSE:EPR) has risen 2.91% since January 14, 2017 and is uptrending. It has underperformed by 13.79% the S&P500.

Analysts await EPR Properties (NYSE:EPR) to report earnings on February, 27. They expect $1.39 earnings per share, up 11.20% or $0.14 from last year’s $1.25 per share. EPR’s profit will be $102.40 million for 10.72 P/E if the $1.39 EPS becomes a reality. After $1.26 actual earnings per share reported by EPR Properties for the previous quarter, Wall Street now forecasts 10.32% EPS growth.

Investors sentiment decreased to 1.13 in 2017 Q3. Its down 0.43, from 1.56 in 2017Q2. It dropped, as 27 investors sold EPR shares while 94 reduced holdings. 42 funds opened positions while 95 raised stakes. 63.43 million shares or 4.76% more from 60.55 million shares in 2017Q2 were reported. The California-based Denali Advsrs Ltd Llc has invested 2.2% in EPR Properties (NYSE:EPR). Moreover, American National Registered Invest Advisor has 0.14% invested in EPR Properties (NYSE:EPR) for 4,095 shares. American Century owns 345,054 shares. Park Avenue Secs Limited Liability Corp accumulated 5,523 shares. 27,857 are owned by Employees Retirement Sys Of Ohio. Hanson Mcclain accumulated 54 shares. Canada Pension Plan Inv Board holds 0% or 5,900 shares in its portfolio. Weiss Multi holds 0.51% or 198,370 shares in its portfolio. Hwg Partnership holds 59 shares. Moreover, Tci Wealth Advisors Incorporated has 0.01% invested in EPR Properties (NYSE:EPR) for 292 shares. Chicago Equity Prtn Ltd holds 0.01% or 5,690 shares. Bailard has 0.02% invested in EPR Properties (NYSE:EPR). Mason Street Advsr Ltd Co has 31,808 shares. Regions Fin Corporation holds 0.01% of its portfolio in EPR Properties (NYSE:EPR) for 11,003 shares. Reilly Advisors Lc reported 0% stake.

Willingdon Wealth Management increased Bgc Partners Inc (NASDAQ:BGCP) stake by 247,691 shares to 366,063 valued at $5.30M in 2017Q3. It also upped Ishares Tr (IVV) stake by 2,427 shares and now owns 22,560 shares. Axon Enterprise Inc was raised too.

Since December 18, 2017, it had 0 insider purchases, and 2 selling transactions for $1.47 million activity. The insider Evans Craig L. sold 14,000 shares worth $840,461. $632,107 worth of stock was sold by Hirons Michael L on Monday, December 18.

Among 10 analysts covering EPR Properties (NYSE:EPR), 3 have Buy rating, 2 Sell and 5 Hold. Therefore 30% are positive. EPR Properties had 18 analyst reports since September 17, 2015 according to SRatingsIntel. The rating was maintained by KeyBanc Capital Markets with “Buy” on Thursday, August 24. The stock of EPR Properties (NYSE:EPR) has “Overweight” rating given on Friday, July 15 by KeyBanc Capital Markets. Stifel Nicolaus maintained the shares of EPR in report on Sunday, August 6 with “Hold” rating. The rating was maintained by Ladenburg with “Buy” on Thursday, November 9. The rating was maintained by FBR Capital with “Hold” on Thursday, November 9. The stock of EPR Properties (NYSE:EPR) has “Buy” rating given on Friday, October 27 by KeyBanc Capital Markets. The rating was initiated by Suntrust Robinson with “Hold” on Tuesday, December 19. As per Friday, August 12, the company rating was maintained by Citigroup. J.P. Morgan downgraded the stock to “Sell” rating in Friday, December 15 report. The rating was downgraded by JP Morgan on Friday, December 16 to “Neutral”.

Breathtec Biomedical, Inc. operates as a medical diagnostics company. The company has market cap of $14.32 million. The firm focuses on developing, in-licensing, and commercializing proprietary breath analysis devices for the early detection of infections and life threatening diseases, such as cancers, liver disease, kidney failure, diabetes, asthma, tuberculosis, neurodegenerative, and others. It currently has negative earnings. It has a strategic alliance and research agreement with ZeptoMetrix Corporation to identify biomarkers associated with the Zika virus.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News